These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26550300)
1. Clinical value of microRNA-23a upregulation in non-small cell lung cancer. Qu WQ; Liu L; Yu Z Int J Clin Exp Med; 2015; 8(8):13598-603. PubMed ID: 26550300 [TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A Microrna; 2019; 8(3):206-215. PubMed ID: 30652656 [TBL] [Abstract][Full Text] [Related]
3. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
4. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Chen SW; Wang TB; Tian YH; Zheng YG Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832 [TBL] [Abstract][Full Text] [Related]
6. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis. Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432 [TBL] [Abstract][Full Text] [Related]
7. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. Mo D; Gu B; Gong X; Wu L; Wang H; Jiang Y; Zhang B; Zhang M; Zhang Y; Xu J; Pan S J Thorac Dis; 2015 Sep; 7(9):1570-9. PubMed ID: 26543604 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer. He Z; Xia Y; Liu B; Qi X; Li Z; Wang J; Chen L; Chen Y J Thorac Dis; 2016 May; 8(5):894-900. PubMed ID: 27162664 [TBL] [Abstract][Full Text] [Related]
10. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. Wang T; Liu X; Tian Q; Liang T; Chang P Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer. Zhang Y; Li H; Han J; Zhang Y Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. Ma G; Dai W; Sang A; Yang X; Gao C Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC. Liu L; Qu W; Zhong Z Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272 [TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
15. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784 [TBL] [Abstract][Full Text] [Related]
17. Tissue microRNA-182 expression level and its potential prognostic value for papillary thyroid carcinoma. Yao XG; Tan Q; Liu PP; Feng LJ Int J Clin Exp Pathol; 2019; 12(8):3128-3133. PubMed ID: 31934155 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-153 expression and prognosis in non-small cell lung cancer. Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma. Wu S; Jia S; Xu P Int J Clin Exp Med; 2014; 7(12):5523-8. PubMed ID: 25664065 [TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer. Li Y; Cui X; Li Y; Zhang T; Li S Cancer Manag Res; 2018; 10():2627-2633. PubMed ID: 30147363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]